Redox environment, free radical, and oxidative DNA damage

Antioxidants and Redox Signaling

Volumn 18, Issue 18, 2013, Pages 2399-2408

  Storr, Sarah J ^a   Woolston, Caroline M ^a   Zhang, Yimin ^a   Martin, Stewart G ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; FREE RADICAL; GLUTAREDOXIN; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOREDOXIN;

CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DNA DAMAGE; DNA REPAIR; ENVIRONMENT; HOMEOSTASIS; HUMAN; NEOPLASM; NEUROLOGIC DISEASE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REVIEW;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DNA DAMAGE; DNA REPAIR; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; NEURODEGENERATIVE DISEASES; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES;

EID: 84878615426     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4920     Document Type: Review

References (116)

1. Alexander A, Cai SL, Kim J, Nanez A, Sahin M, MacLean KH, Inoki K, Guan KL, Shen J, Person MD, Kusewitt D, Mills GB, Kastan MB, and Walker CL. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci USA 107: 4153-4158, 2010.
2. Andrews BJ, Lehman JA, and Turchi JJ. Kinetic analysis of the Ku-DNA binding activity reveals a redox-dependent alteration in protein structure that stimulates dissociation of the Ku-DNA complex. J Biol Chem 281: 13596-13603, 2006.
3. Ayene IS, Stamato TD, Mauldin SK, Biaglow JE, Tuttle SW, Jenkins SF, and Koch CJ. Mutation in the glucose-6-phos-phate dehydrogenase gene leads to inactivation of Ku DNA end binding during oxidative stress. J Biol Chem 277: 9929-9935, 2002.
4. Bae I, Fan S, Meng Q, Rih JK, Kim HJ, Kang HJ, Xu J, Goldberg ID, Jaiswal AK, and Rosen EM. BRCA1 induces antioxidant gene expression and resistance to oxidative stress. Cancer Res 64: 7893-7909, 2004.
5. Bennett SM, Neher TM, Shatilla A, and Turchi JJ. Molecular analysis of Ku redox regulation. BMC Mol Biol 10: 86, 2009.
6. Bhakat KK, Mokkapati SK, Boldogh I, Hazra TK, and Mitra S. Acetylation of human 8-oxoguanine-DNA glycosylase by p300 and its role in 8-oxoguanine repair in vivo. Mol Cell Biol 26: 1654-1665, 2006.
7. Bravard A, Vacher M, Gouget B, Coutant A, de Boisferon FH, Marsin S, Chevillard S, and Radicella JP. Redox regulation of human OGG1 activity in response to cellular oxi-dative stress. Mol Cell Biol 26: 7430-7436, 2006.
8. Bravard A, Vacher M, Moritz E, Vaslin L, Hall J, Epe B, and Radicella JP. Oxidation status of human OGG1-S326C polymorphic variant determines cellular DNA repair capacity. Cancer Res 69: 3642-3649, 2009.
9. Bruner SD, Norman DP, and Verdine GL. Structural basis for recognition and repair of the endogenous mutagen 8-oxoguanine in DNA. Nature 403: 859-866, 2000.
10. Cadet J, Douki T, and Ravanat JL. Oxidatively generated base damage to cellular DNA. Free Radic Biol Med 49: 9-21, 2010.
11. Cosentino C, Grieco D, and Costanzo V. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J 30: 546-555, 2011.
12. Cuneo MJ, and London RE. Oxidation state of the XRCC1 N-terminal domain regulates DNA polymerase beta binding affinity. Proc Natl Acad Sci USA 107: 6805-6810, 2010.
13. D'Errico M, Parlanti E, and Dogliotti E. Mechanism of oxi-dative DNA damage repair and relevance to human pathology. Mutat Res 659: 4-14, 2008.
14. Dai J, Li W, Chang L, Zhang Z, Tang C, Wang N, Zhu Y, and Wang X. Role of redox factor-1 in hyperhomocysteinemia-accelerated atherosclerosis. Free Radic Biol Med 41: 1566-1577, 2006.
15. Dally H, and Hartwig A. Induction and repair inhibition of oxidative DNA damage by nickel(II) and cadmium(II) in mammalian cells. Carcinogenesis 18: 1021-1026, 1997.
16. Das S, Chattopadhyay R, Bhakat KK, Boldogh I, Kohno K, Prasad R, Wilson SH, and Hazra TK. Stimulation of NEIL2-mediated oxidized base excision repair via YB-1 interaction during oxidative stress. J Biol Chem 282: 28474-28484, 2007.
17. David SS, O'Shea VL, and Kundu S. Base-excision repair of oxidative DNA damage. Nature 447: 941-950, 2007.
18. Demple B, and Harrison L. Repair of oxidative damage to DNA: Enzymology and biology. Annu Rev Biochem 63: 915-948, 1994.
19. Demple B, Herman T, and Chen DS. Cloning and expression of APE, the cDNA encoding the major human apurinic en-donuclease: Definition of a family of DNA repair enzymes. Proc Natl Acad Sci USA 88: 11450-11454, 1991.
20. Dianova, II, Bohr VA, and Dianov GL. Interaction of human AP endonuclease 1 with flap endonuclease 1 and proliferating cell nuclear antigen involved in long-patch base excision repair. Biochemistry 40: 12639-12644, 2001.
21. Dincer Y, Akcay T, Alademir Z, and Ilkova H. Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. Mutat Res 505: 75-81, 2002.
22. Eklund H, Cambillau C, Sjoberg BM, Holmgren A, Jornvall H, Hoog JO, and Branden CI. Conformational and functional similarities between glutaredoxin and thioredoxins. EMBO J 3: 1443-1449, 1984.
23. Evans AR, Limp-Foster M, and Kelley MR. Going APE over ref-1. Mutat Res 461: 83-108, 2000.
24. Evans MD, Dizdaroglu M, and Cooke MS. Oxidative DNA damage and disease: Induction, repair and significance. Mutat Res 567: 1-61, 2004.
25. Fattman CL, Schaefer LM, and Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Rad Biol Med 35: 236-256, 2003.
26. Fernandes AP, Fladvad M, Berndt C, Andresen C, Lillig CH, Neubauer P, Sunnerhagen M, Holmgren A, and Vlamis-Gardikas A. A novel monothiol glutaredoxin (Grx4) from Escherichia coli can serve as a substrate for thioredoxin re-ductase. J Biol Chem 280: 24544-24552, 2005.
27. Finkel T. Signal transduction by reactive oxygen species. J Cell Biol 194: 7-15, 2011.
28. Fishel ML, Jiang Y, Rajeshkumar NV, Scandura G, Sinn AL, He Y, Shen C, Jones DR, Pollok KE, Ivan M, Maitra A, and Kelley MR. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth. Mol Cancer Ther 10: 1698-1708, 2011.
29. Frosina G. Overexpression of enzymes that repair endogenous damage to DNA. Eur J Biochem 267: 2135-2149, 2000.
30. Gasdaska JR, Berggren M, and Powis G. Cell-growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Cell Growth Different 6: 1643-1650, 1995.
31. Gladyshev VN, Jeang KT, and Stadtman TC. Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc Natl Acad Sci USA 93: 6146-6151, 1996.
32. Go YM, and Jones DP. Redox control systems in the nucleus: Mechanisms and functions. Antioxid Redox Signal 13: 489-509, 2010.
33. Gros L, Saparbaev MK, and Laval J. Enzymology of the repair of free radicals-induced DNA damage. Oncogene 21: 8905-8925, 2002.
34. Guo Z, Kozlov S, Lavin MF, Person MD, and Paull TT. ATM activation by oxidative stress. Science 330: 517-521, 2010.
35. Ha HC, and Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 96: 13978-13982, 1999.
36. Hall A, Karplus PA, and Poole LB. Typical 2-Cys peroxir-edoxins- Structures, mechanisms and functions. FEBS J 276: 2469-2477, 2009.
37. Herrero E, Belli G, and Casa C. Structural and functional diversity of glutaredoxins in yeast. In: Curr Protein Pept Sci, Netherlands, 2010, pp 659-668.
38. Herring CJ, Deans B, Elder RH, Rafferty JA, MacKinnon J, Barzilay G, Hickson ID, Hendry JH, and Margison GP. Expression levels of the DNA repair enzyme HAP1 do not correlate with the radiosensitivities of human or HAP1-transfected rat cell lines. Br J Cancer 80: 940-945, 1999.
39. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA 94: 3633-3638, 1997.
40. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, and Yodoi J. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem 274: 27891-27897, 1999.
41. Hsieh MM, Hegde V, Kelley MR, and Deutsch WA. Activation of APE/Ref-1 redox activity is mediated by reactive oxygen species and PKC phosphorylation. Nucleic Acids Res 29: 3116-3122, 2001.
42. Hsu GW, Ober M, Carell T, and Beese LS. Error-prone replication of oxidatively damaged DNA by a high-fidelity DNA polymerase. Nature 431: 217-221, 2004.
43. Hussain SP, Hofseth LJ and Harris CC. Radical causes of cancer. Nat Rev Cancer 3: 276-285, 2003.
44. Jackson SP, and Bartek J. The DNA-damage response in human biology and disease. Nature 461: 1071-1078, 2009.
45. Jensen A, Lohr M, Eriksen L, Gronbaek M, Dorry E, Loft S, and Moller P. Influence of the OGG1 Ser326Cys polymorphism on oxidatively damaged DNA and repair activity. Free Radic Biol Med 52: 118-125, 2012.
46. Johansson C, Lillig CH, and Holmgren A. Human mito-chondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J Biol Chem 279: 7537-7543, 2004.
47. Junn E, Han SH, Im JY, Yang Y, Cho EW, Um HD, Kim DK, Lee KW, Han PL, Rhee SG, and Choi I. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol US 2000:6287-6295.
48. Kakolyris S, Giatromanolaki A, Koukourakis M, Kaklamanis L, Kanavaros P, Hickson ID, Barzilay G, Georgoulias V, Gatter KC, and Harris AL. Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC). J Pathol 189: 351-357, 1999.
49. Kakolyris S, Kaklamanis L, Engels K, Fox SB, Taylor M, Hickson ID, Gatter KC, and Harris AL. Human AP endo-nuclease 1 (HAP1) protein expression in breast cancer correlates with lymph node status and angiogenesis. Br J Cancer 77: 1169-1173, 1998.
50. Kamsler A, Daily D, Hochman A, Stern N, Shiloh Y, Rotman G, and Barzilai A. Increased oxidative stress in ataxia tel-angiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res 61: 1849-1854, 2001.
51. Kelley MR, Cheng L, Foster R, Tritt R, Jiang J, Broshears J, and Koch M. Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer. Clin Cancer Res 7: 824-830, 2001.
52. Kelley MR, and Parsons SH. Redox regulation of the DNA repair function of the human AP endonuclease Ape1/ref-1. Antioxid Redox Signal 3: 671-683, 2001.
53. Langie SA, Knaapen AM, Houben JM, van Kempen FC, de Hoon JP, Gottschalk RW, Godschalk RW, and van Schooten FJ. The role of glutathione in the regulation of nucleotide excision repair during oxidative stress. Toxicol Lett 168: 302-309, 2007.
54. Li H, Hao X, Zhang W, Wei Q, and Chen K. The hOGG1 Ser326Cys polymorphism and lung cancer risk: A meta-analysis. Cancer Epidemiol Biomarkers Prev 17: 1739-1745, 2008.
55. Li Q, Ding L, Yu JJ, Mu C, Tsang B, Bostick-Bruton F, and Reed E. Cisplatin and phorbol ester independently induce ERCC-1 protein in human ovarian carcinoma cells. Int J Oncol 13: 987-992, 1998.
56. Li Q, Zhang L, Tsang B, Gardner K, Bostick-Bruton F, and Reed E. Phorbol ester exposure activates an AP-1-mediated increase in ERCC-1 messenger RNA expression in human ovarian tumor cells. Cell Mol Life Sci 55: 456-466, 1999.
57. Lillig CH, Berndt C, and Holmgren A. Glutaredoxin systems. Biochim Biophys Acta-General Subjects 1780: 1304-1317, 2008.
58. Lillig CH, Berndt C, Vergnolle O, Lonn ME, Hudemann C, Bill E, and Holmgren A. Characterization of human glutar-edoxin 2 as iron-sulfur protein: A possible role as redox sensor. Proc Natl Acad Sci USA 102: 8168-8173, 2005.
59. Loeb LA, and Preston BD: Mutagenesis by apurinic/apyr-imidinic sites. Annu Rev Genet 20: 201-230, 1986.
60. Luo M, Delaplane S, Jiang A, Reed A, He Y, Fishel M, Ny-land RL, 2nd, Borch RF, Qiao X, Georgiadis MM, and Kelley MR. Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: Small-molecule inhibition of the redox function of Ape1. Antioxid Redox Signal 10: 1853-1867, 2008.
61. Luo M, He H, Kelley MR, and Georgiadis MM. Redox regulation of DNA repair: Implications for human health and cancer therapeutic development. Antioxid Redox Signal 12: 1247-1269, 2010.
62. Manevich Y, and Fisher AB. Peroxiredoxin 6, a 1-Cys per-oxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic Biol Med 38: 1422-1432, 2005.
63. Marcon G, Tell G, Perrone L, Garbelli R, Quadrifoglio F, Tagliavini F, and Giaccone G. APE1/Ref-1 in Alzheimer's disease: An immunohistochemical study. Neurosci Lett 466: 124-127, 2009.
64. Martinet W, Knaapen MW, De Meyer GR, Herman AG, and Kockx MM. Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques. Circulation 106: 927-932, 2002.
65. Maynard S, Schurman SH, Harboe C, de Souza-Pinto NC, and Bohr VA. Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis 30: 2-10, 2009.
66. McCord JM, Keele BB, Jr., and Fridovich I. An enzyme-based theory of obligate anaerobiosis: The physiological function of superoxide dismutase. Proc Natl Acad Sci USA 68: 1024-1027, 1971.
67. Meister A. Glutathione ascorbic-acid antioxidant system in animals. J Biol Chem 269: 9397-9400, 1994.
68. Melis JP, Luijten M, Mullenders LH, and van Steeg H. The role of XPC: Implications in cancer and oxidative DNA damage. Mutat Res 728: 107-117, 2011.
69. Men L, Roginskaya M, Zou Y, and Wang Y. Redox-dependent formation of disulfide bonds in human replication protein A. Rapid Commun Mass Spectrom 21: 2743-2749, 2007.
70. Mokkapati SK, Wiederhold L, Hazra TK, and Mitra S. Stimulation of DNA glycosylase activity of OGG1 by NEIL1: Functional collaboration between two human DNA glyco-sylases. Biochemistry 43: 11596-11604, 2004.
71. Moore DH, Michael H, Tritt R, Parsons SH, and Kelley MR. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers. Clin Cancer Res 6: 602-609, 2000.
72. Mustacich D, and Powis G. Thioredoxin reductase. Biochem J 346: 1-8, 2000.
73. Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, Bronson RT, Fujiwara Y, Orkin SH, and Van Etten RA. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424: 561-565, 2003.
74. Nguyen-nhu NT, Berck J, Clippe A, Duconseille E, Cherif H, Boone C, Van der Eecken V, Bernard A, Banmeyer I, and Knoops B. Human peroxiredoxin 5 gene organization, initial characterization of its promoter and identification of alternative forms of mRNA. Biochim Biophys Acta-Gene Structure Expression 1769: 472-483, 2007.
75. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, and Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D-3 up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274: 21645-21650, 1999.
76. Noren Hooten N, Kompaniez K, Barnes J, Lohani A, and Evans MK. Poly(ADP-ribose) polymerase 1 (PARP-1) binds to 8-oxoguanine-DNA glycosylase (OGG1). J Biol Chem 286: 44679-44690, 2011.
77. Parildar-Karpuzoglu H, Dogru-Abbasoglu S, Hanagasi HA, Karadag B, Gurvit H, Emre M, and Uysal M. Single nucle-otide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer's disease. Neurosci Lett 442: 287-291, 2008.
78. Peng D, Belkhiri A, Hu T, Chaturvedi R, Asim M, Wilson KT, Zaika A, and El-Rifai W. Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells. Gut 61: 1250-1260, 2012.
79. Pennington JD, Wang TJ, Nguyen P, Sun L, Bisht K, Smart D, and Gius D. Redox-sensitive signaling factors as a novel molecular targets for cancer therapy. Drug Resist Updat 8: 322-330, 2005.
80. Pines A, Perrone L, Bivi N, Romanello M, Damante G, Gu-lisano M, Kelley MR, Quadrifoglio F, and Tell G. Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res 33: 4379-4394, 2005.
81. Powis G, and Montfort WR. Properties and biological activities of thioredoxins. Ann Rev Pharmacol Toxicol 41: 261-295, 2001.
82. Powis G, Mustacich D, and Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Rad Biol Med 29: 312-322, 2000.
83. Ramana CV, Boldogh I, Izumi T, and Mitra S. Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci USA 95: 5061-5066, 1998.
84. Robson CN, and Hickson ID. Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease III) mutants. Nucleic Acids Res 19: 5519-5523, 1991.
85. Saha T, Rih JK, and Rosen EM. BRCA1 down-regulates cellular levels of reactive oxygen species. FEBS Lett 583: 1535-1543, 2009.
86. Shibutani S, Takeshita M, and Grollman AP. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 349: 431-434, 1991.
87. Sidorenko VS, Nevinsky GA, and Zharkov DO. Mechanism of interaction between human 8-oxoguanine-DNA glycosy-lase and AP endonuclease. DNA Repair (Amst) 6: 317-328, 2007.
88. Simone S, Gorin Y, Velagapudi C, Abboud HE, and Habib SL. Mechanism of oxidative DNA damage in diabetes: Tu-berin inactivation and downregulation of DNA repair enzyme 8-oxo-7, 8-dihydro-2'-deoxyguanosine-DNA glycosylase. Diabetes 57: 2626-2636, 2008.
89. Sporn MB, and Liby KT. NRF2 and cancer: The good, the bad and the importance of context. Nat Rev Cancer 12: 564-571, 2012.
90. Storr SJ, Woolston CM, and Martin SG. Base excision repair, the redox environment and therapeutic implications. Curr Mol Pharmacol 5: 88-101, 2012.
91. Svilar D, Goellner EM, Almeida KH, and Sobol RW. Base excision repair and lesion-dependent subpathways for repair of oxidative DNA damage. Antioxid Redox Signal 14: 2491-2507, 2011.
92. Tachi Y, Okuda Y, Bannai C, Okamura N, Bannai S, and Yamashita K. High concentration of glucose causes impairment of the function of the glutathione redox cycle in human vascular smooth muscle cells. FEBS Lett 421: 19-22, 1998.
93. Tavender TJ, Sheppard AM, and Bulleid NJ. Peroxiredoxin IV is an endoplasmic reticulum-localized enzyme forming oligomeric complexes in human cells. Biochemical J 411: 191-199, 2008.
94. Totter JR. Spontaneous cancer and its possible relationship to oxygen metabolism. Proc Natl Acad Sci USA 77: 1763-1767, 1980.
95. Ueno M, Masutani H, Arai RJ, Yamauchi A, Hirota K, Sakai T, Inamoto T, Yamaoka Y, Yodoi J, and Nikaido T. Thior-edoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem 274: 35809-35815, 1999.
96. Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 11: 1289-1299, 2009.
97. Valko M, Izakovic M, Mazur M, Rhodes CJ, and Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266: 37-56, 2004.
98. Watson WH, Chen Y, and Jones DP. Redox state of gluta-thione and thioredoxin in differentiation and apoptosis (Reprinted from Thiol Metabolism and Redox Regulation of Cellular Functions). Biofactors 17: 307-314, 2003.
99. Wei SJ, Botero A, Hirota K, Bradbury CM, Markovina S, Laszlo A, Spitz DR, Goswami PC, Yodoi J, and Gius D. Thioredoxin nuclear translocation and interaction with re-dox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res 60: 6688-6695, 2000.
100. Weydert CJ, and Cullen JJ. Measurement of superoxide dismutase, catalase and glutathione peroxidase in cultured cells and tissue. Nature Protocols 5: 51-66, 2010.
101. Witte S, Villalba M, Bi K, Liu Y, Isakov N, and Altman A. Inhibition of the c-Jun N-terminal kinase/AP-1 and NF-kappaB pathways by PICOT, a novel protein kinase C-interacting protein with a thioredoxin homology domain. J Biol Chem 275: 1902-1909, 2000.
102. Wood ZA, Poole LB, and Karplus PA. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 300: 650-653, 2003.
103. Woolston CM, Al-Attar A, Storr SJ, Ellis IO, Morgan DA, and Martin SG. Redox protein expression predicts radiotherapeutic response in early-stage invasive breast cancer patients. Int J Radiat Oncol Biol Phys 79: 1532-1540, 2011.
104. Woolston CM, Deen S, Al-Attar A, Shehata M, Chan SY, and Martin SG. Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy. Free Radic Biol Med 49: 1263-1272, 2010.
105. Woolston CM, Storr SJ, Ellis IO, Morgan DA, and Martin SG. Expression of thioredoxin system and related peroxir-edoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancer. Radiother Oncol 100: 308-313, 2011.
106. Woolston CM, Zhang L, Storr SJ, Al-Attar A, Shehata M, Ellis IO, Chan SY, and Martin SG. The prognostic and predictive power of redox protein expression for anthra-cycline-based chemotherapy response in locally advanced breast cancer. Mod Pathol 25: 1106-1116, 2012.
107. Wu WS. The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev 25: 695-705, 2006.
108. Xanthoudakis S, and Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11: 653-665, 1992.
109. Xanthoudakis S, Miao GG, and Curran T. The redox and DNA-repair activities of Ref-1 are encoded by nonover-lapping domains. Proc Natl Acad Sci USA 91: 23-27, 1994.
110. Xu Y, Moore DH, Broshears J, Liu L, Wilson TM, and Kelley MR. The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalig-nant and malignant cervical cancer. Anticancer Res 17: 3713-3719, 1997.
111. Yamanaka H, Maehira F, Oshiro M, Asato T, Yanagawa Y, Takei H, and Nakashima Y. A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system. Biochem Biophys Res Commun 271: 796-800, 2000.
112. Yang S, Irani K, Heffron SE, Jurnak F, and Meyskens FL, Jr. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE/Ref-1) in human melanoma and identification of the therapeutic potential of resveratrol as an APE/Ref-1 inhibitor. Mol Cancer Ther 4: 1923-1935, 2005.
113. Zahedi Avval F, and Holmgren A. Molecular mechanisms of thioredoxin and glutaredoxin as hydrogen donors for mammalian s phase ribonucleotide reductase. J Biol Chem 284: 8233-8240, 2009.
114. Zhang H, Xu Y, Zhang Z, and Li L. The hOGG1 Ser326Cys polymorphism and prostate cancer risk: A meta-analysis of 2584 cases and 3234 controls. BMC Cancer 11: 391, 2011.
115. Zhang Y, Ikeno Y, Qi W, Chaudhuri A, Li Y, Bokov A, Thorpe SR, Baynes JW, Epstein C, Richardson A, and Van Remmen H. Mice deficient in both Mn superoxide dis-mutase and glutathione peroxidase-1 have increased oxi-dative damage and a greater incidence of pathology but no reduction in longevity. J Gerontol A Biol Sci Med Sci 64: 1212-1220, 2009.
116. Zou GM, and Maitra A. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration. Mol Cancer Ther 7: 2012-2021, 2008.